ExodusPoint Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.81M	Buy	+190,058	New	+$1.48M	0.02%	817
2025 Q4	–	Sell	-364,457	Closed	-$2.77M	–	1549
2025 Q3	$2.77M	Buy	364,457 +153,617	+73%	+$1.28M	0.04%	620
2025 Q2	$1.89M	Buy	210,840 +149,907	+246%	+$1.4M	0.02%	768
2025 Q1	$457K	Buy	+60,933	New	+$491K	0.01%	1125
2024 Q2	–	Sell	-172,961	Closed	-$879K	–	1536
2024 Q1	$879K	Sell	172,961 -19,241	-10%	-$108K	0.01%	988
2023 Q4	$1.15M	Sell	192,202 -557,851	-74%	-$3.23M	0.01%	764
2023 Q3	$5.31M	Sell	750,053 -462,494	-38%	-$3.32M	0.07%	359
2023 Q2	$8.54M	Sell	1,212,547 -9,134	-0.7%	-$73.3K	0.1%	286
2023 Q1	$10.2M	Buy	1,221,681 +1,199,839	+5,493%	+$11.6M	0.12%	275
2022 Q4	$251K	Sell	21,842 -687,443	-97%	-$8.57M	﹤0.01%	1405
2022 Q3	$8.94M	Buy	709,285 +366	+0.1%	+$4.71K	0.12%	234
2022 Q2	$7.5M	Buy	+708,919	New	+$7.31M	0.11%	271
2022 Q1	–	Sell	-120,827	Closed	-$1.67M	–	2196
2021 Q4	$1.67M	Buy	120,827 +78,532	+186%	+$1.04M	0.02%	837
2021 Q3	$608K	Sell	42,295 -79,308	-65%	-$1.25M	0.01%	1277
2021 Q2	$1.92M	Buy	+121,603	New	+$1.65M	0.03%	700
2020 Q3	–	Sell	-35,969	Closed	-$171K	–	1746
2020 Q2	$171K	Buy	+35,969	New	+$144K	0.01%	1546